Skip to main content

Month: June 2024

Paradies Lagardère Introduces ARHT Holograms in New Retail Experience at Toronto Pearson International Airport

TORONTO, June 03, 2024 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or “the Company”) (TSXV: ART), (OTCQB: ARHTF) the global leader in the development, production and distribution of high-quality, low latency hologram and digital content, is excited to announce that ARHT CAPSULE will be featured in Paradies Lagardère’s newest retail engagement, The Goods Express@YYZ, at Toronto Pearson International Airport. This innovative, checkout-free retail experience also includes Amazon’s Just Walk Out technology, showcasing the seamless integration of advanced retail and digital technologies. The location’s unveiling marks the first in-store use of the ARHT CAPSULE in a Canadian airport. This innovative technology was introduced to Toronto Pearson travelers during the holidays with a seasonal promotion and will...

Continue reading

TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement and Receives an Extension on Compliance with Nasdaq Filing Requirement

BEIJING, June 03, 2024 (GLOBE NEWSWIRE) — TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the “Company”), a China-based insurance broker conducting business through its variable interest entity in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on May 29, 2024, informing the Company that it has regained compliance with Nasdaq’s minimum bid price requirement under Listing Rule 5550(a)(2). According to the Notification Letter, as of May 28, 2024, the Company has maintained a closing bid price of $1.00 per share or greater for ten consecutive business days. In addition, the Company received a letter from Nasdaq on May 29, 2024 (the “Extension Notice”), granting the Company an extension until August 15,...

Continue reading

Cyber Security Market is expected to Grow from USD 168.04 Billion 2023 to reach USD 452.08 Billion in 2031

Westford,USA, June 03, 2024 (GLOBE NEWSWIRE) — Cyber security refers to the security of digital platforms and digital assets. The rapidly evolving cyber threat landscape, high incidence of data breaches and cyberattacks, and imposition of strict data privacy and security regulations are key factors that are promoting the demand for better cyber security around the world. Remote work and bring your own device (BYOD) are also key trends that have bolstered the importance of advanced cyber security measures around the world. The global cyber security market is segmented into solution type, deployment mode, organization size, security type, vertical, and region. Download a detailed overview: https://www.skyquestt.com/sample-request/cyber-security-market IAM Remains Imperative for Cyber Security Identity and access management (IAM)...

Continue reading

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

The trial will be conducted in the U.S. and its results will complement the preclinical data on the LIBERTY® Endovascular Robotic Surgical System, which together are expected to support a future 510(k) submission BRAINTREE, Mass., June 03, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announces that it has received the U.S. Food and Drug Administration’s (“FDA”) approval to proceed with its pivotal human clinical trial as part of its Investigational Device Exemption (“IDE”) application for its LIBERTY® Endovascular Robotic Surgical System. The study will be conducted in the U.S., and the Company has already signed a clinical trial service agreement with a leading academic medical center. The Company is also in the process of engaging...

Continue reading

Kelly Completes Acquisition of Motion Recruitment Partners, LLC

Transformational acquisition expected to accelerate EBITDA margin expansion MRP to continue delivering services through existing operating companies and brands Kelly management to host live webcast on June 18 to provide more details about the rationale for the acquisition and insights into MRP’s financial profileTROY, Mich., June 03, 2024 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA, KELYB) (“the Company”), a leading global specialty talent solutions provider, today announced it has completed the acquisition of Motion Recruitment Partners, LLC (“MRP”), from Littlejohn & Co., LLC (“Littlejohn”), a private investment firm based in Greenwich, Connecticut. Kelly previously announced on May 3, 2024, that it had entered into a definitive agreement to acquire MRP from Littlejohn. The acquisition of MRP strengthens the scale and capabilities...

Continue reading

Ex-dividend date of Enefit Green is 10 June 2024

Enefit Green (trading code EGR1T, ISIN code EE3100137985) will establish the list of shareholders entitled to receive dividend payment on 11 June 2024 at the end of the working day of the Nasdaq CSD settlement system (record date). Proceeding from the above, the ex-dividend date is 10 June 2024. From that date onwards the buyer of the shares is not entitled to receive dividends for the financial year 2023. Enefit Green will pay dividend €0.105 per share on 18 June 2024.Further information: Sven Kunsing Head of Finance Communication investor@enefitgreen.ee https://enefitgreen.ee/en/investorile/ Enefit Green is one of the leading renewable energy producers in the Baltic Sea area. The Company operates wind farms in Estonia and Lithuania, waste-to-energy CHP plant in Estonia, solar farms in Estonia and Poland and a hydroelectric plant in...

Continue reading

Evaxion Presents Positive and Validating Immune Data from Ongoing Phase 2 Trial with AI-Designed EVX-01 Vaccine at the ASCO Annual Meeting 2024

Evaxion’s AI-designed cancer vaccine, EVX-01, triggered a specific and tumor-targeting immune response in all assayed melanoma patientsFindings further confirm and validate the precision and predictive power of Evaxion’s AI vaccine target discovery and design platform, AI-Immunology™COPENHAGEN, Denmark, June 03, 2024 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, reported data from its ongoing Phase 2 study at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024. The data demonstrated vaccine-induced immune response in metastatic melanoma patients treated with the Company’s AI-Immunology™ designed personalized cancer vaccine, EVX-01, in combination with an anti-PD1...

Continue reading

EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations

New appointments bring significant commercial experience with a focus on growing key strategic markets Expands executive leadership in growing disruptive, robotics-based capital equipment in both Urology and Gynecology therapeutic applications LYON, France, June 3, 2024 – EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced the appointments of Damien Desmedt and Alexander Fromm to further strengthen the Company’s European and Middle Eastern commercial leadership. Mr. Desmedt has been appointed Vice President of Sales for Europe, Middle East, Africa, and India (EMEAI), and Mr. Fromm has been appointed General Manager for Switzerland and will oversee several strategic European territories. “We are pleased to announce the expansion of our international commercial leadership team with the...

Continue reading

Vaisala Corporation’s conveyance of treasury shares in accordance with share-based incentive plan

Vaisala CorporationStock exchange releaseJune 3, 2024, at 3:00 p.m. (EEST) Vaisala Corporation’s conveyance of treasury shares in accordance with share-based incentive plan A total of 1,750 of Vaisala Corporation’s treasury shares have been conveyed without consideration to persons participating in the Restricted Share Unit Plan 2022–2026 under the terms and conditions of the plan. The directed share issue was based on an authorization given by the Annual General Meeting held on March 26, 2024. Following this directed share issue, the number of series A treasury shares is 137,378. Additional informationPaula Liimatta+358 9 8949 2020, ir@vaisala.com DistributionNasdaq Helsinki Key mediavaisala.com Vaisala is a global leader in measurement instruments and intelligence for climate action. We equip our customers with devices and data...

Continue reading

Apogee Minerals Announces Appointment of New Director

Vancouver, British Columbia, June 03, 2024 (GLOBE NEWSWIRE) — Apogee Minerals Ltd. (“Apogee” or the “Company”) (TSXV: APMI) is pleased to announce the appointment of Mr. Nicholas Coltura as a Director of the Company. Mr. Coltura is a seasoned Investor Relations Manager specializing in the junior resource sector, working with different junior mining companies listed on the TSXV, CSE and OTC public markets. With several years of experience, Mr. Coltura has honed his expertise in communicating important public company information to a diverse range of investors and stakeholders. Throughout his career, Nicholas has been instrumental in building and maintaining strong relationships with investors and industry partners. His strategic approach to investor relations has successfully enhanced company visibility, fostered key relationships,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.